Efficacy of tolvaptan for the patients with advanced hepatocellular carcinoma

AIM: To investigate the factors influenced the efficacy of tolvaptan (TLV) in liver cirrhosis. METHODS: We retrospectively enrolled 61 consecutive patients with refractory hepatic ascites. All of them had been treated with furosemide and spironolactone before admission, and treated with TLV for 7 d...

Descripción completa

Detalles Bibliográficos
Autores principales: Miyazaki, Masayuki, Yada, Masayoshi, Tanaka, Kosuke, Senjyu, Takeshi, Goya, Takeshi, Motomura, Kenta, Kohjima, Motoyuki, Kato, Masaki, Masumoto, Akihide, Kotoh, Kazuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2017
Materias:
Retrospective Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5550787/
https://www.ncbi.nlm.nih.gov/pubmed/28839438
http://dx.doi.org/10.3748/wjg.v23.i29.5379

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5550787/
https://www.ncbi.nlm.nih.gov/pubmed/28839438
http://dx.doi.org/10.3748/wjg.v23.i29.5379

Ejemplares similares